Teleflex Incorporated

NYSE:TFX  
393.39
-3.01 (-0.76%)
Debt Financing / Related, Divestitures / Spin-offs, Other Pre-Announcement

Teleflex Signs Definitive Agreement To Sell Certain Respiratory Assets And Reaffirms Adjusted EPS Guidance

Published: 05/18/2021 10:38 GMT
Teleflex Incorporated (TFX) - Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance.
Teleflex Inc - Total Consideration of Deal is $286 Million, Reduced by $12 Million of Working Capital to Be Retained by Teleflex.
Teleflex Inc - Maintaining Its Current 2021 Adjusted Diluted Earnings per Share Guidance Range.
Teleflex Inc - 2021 Headwinds Are Estimated at $28 Million-32 Million in Revenue and $0.10-$0.15 in Adjusted Diluted Earnings per Share.
Teleflex Inc - Intends to Use Divestiture Proceeds to Pay Down Debt.
Teleflex Inc - Transaction is Accretive to Our Pro-forma Revenue Growth Profile, As Well As Adjusted Gross and Operating Margins Longer Term.